Lilly and Novo are facing off in the lucrative global obesity market, which analysts expect to reach $100 billion by the end ...

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

This is the second time Eli Lilly has cut prices of Zepbound on LillyDirect. The pharmaceutical company said it is making the ...

This is the second time the company has cut down prices of Zepbound on LillyDirect. Eli Lilly said it was making the weight ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

Lilly drops Zepbound single-dose vial prices on LillyDirect, offering lower costs and more access options for patients with a valid prescription.

The FTSE 100 index closed down 17.98 points, 0.2%, at 9,702.53. The FTSE 250 ended down 144.49 points, 0.7%, at 22,020.68, ...

Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.

PEZ celebrates Thanksgiving with gratitude for the 2025 cycling season: Pogačar's dominance, van der Poel's brilliance, ...

The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.